top of page
    • Feb 8

Bruce Levine on UPenn's Center for Cellular Immunotherapies and his thoughts regarding FDA's recent CAR-T guidance

Dr. Levine highlights work being done at UPenn including a 3-day CAR with IL-18 and a dual CAR targeting GBM. Plus, his reaction to the secondary malignancy topic that has been in the news.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

@BiotechTVHQ

BiotechTV

BiotechTVHQ

@BiotechTV

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

bp-logo.png

Breakthrough Properties is a life science real estate company that is exclusively focused on delivering cutting-edge environments for the life science industry. With a portfolio of roughly 5 million square feet across the US, UK and continental Europe, Breakthrough has emerged as a leading partner for high-growth biotechs and pharmas around the world. 

Visit Breakthrough Properties

bottom of page